PRICE T ROWE ASSOCIATES INC /MD/
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$345,943,976
-$128,109,354 QoQ
Shares Held
1,149,201
-19.8% QoQ
Ownership
0.859%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#20
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. ALNY ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,943,976 | 1,149,201 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $474,053,330 | 1,432,748 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $677,130,746 | 1,702,831 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $820,934,064 | 1,800,294 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,025,555,006 | 3,145,006 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $946,465,463 | 3,505,168 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $781,084,483 | 3,319,385 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $949,357,629 | 3,451,833 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $847,584,729 | 3,488,003 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $550,835,785 | 3,685,753 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $666,866,506 | 3,483,969 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $695,118,207 | 3,925,004 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $738,018,707 | 3,885,536 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $795,846,519 | 3,972,876 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $968,220,321 | 4,074,144 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $744,716,496 | 3,720,606 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,020,524,409 | 6,997,082 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,109,419,366 | 6,794,166 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,108,267,705 | 6,535,368 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,109,114,310 | 5,874,235 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $936,543,414 | 5,524,678 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $787,164,323 | 5,575,213 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $724,627,199 | 5,575,342 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $875,762,305 | 6,014,851 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $929,009,014 | 6,272,426 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $684,422,676 | 6,287,760 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||